However, since TNBCs constitute about 15% of all breast cancers, while hormone receptor-positive breast cancers comprise about 70% of all breast cancers, there is actually a greater number of hormone receptor-positive breast cancer patients who are gBRCAMUT. Here, NR4A1 is linked to breast carcinoma.